NanoString results showed that all genes in the first set behaved as expected: expression of FASLG, FCRL6, GZMB, KLRD1, and IGFBP3 were reduced while expression of ZNF680 was increased in TN-T1D vs. Tempus controls and UF-T1D vs. PAXgene controls. The gene discussed is IGFBP3; the disease is type 1 diabetes mellitus.